Results for tag: "Cancer Tissue Diagnostics"

The Cancer Tissue Diagnostics market is a subsegment within the broader field of medical diagnostics that focuses specifically on the detection and diagnosis of cancer using tissue samples. This sphere employs various techniques to analyze biopsies and identify the presence, stage, and sometimes the specific subtype of cancer. Histopathology, which involves the microscopic examination of tissue in order to study the manifestations of disease, forms the cornerstone of this market. Other methodologies commonly used include immunohistochemistry (IHC), which utilizes antibodies to detect specific antigens in the cancer cells, and in situ hybridization (ISH) techniques, such as fluorescence in situ hybridization (FISH), that localize genetic materials within the cells. These diagnostic methods help in formulating personalized treatment plans and prognostic assessments for patients. In the realm of Cancer Tissue Diagnostics, several prominent companies are engaged in the development, manufacturing, and marketing of diagnostics equipment and consumables. Some key players include Roche Diagnostics, a division of Hoffmann-La Roche Ltd, known for its comprehensive diagnostics solutions. Danaher Corporation, through its subsidiary Leica Biosystems, also provides advanced staining and imaging solutions for cancer diagnostics. Other notable firms include Agilent Technologies, which offers a range of pathology solutions, and Thermo Fisher Scientific, with its portfolio of instruments and reagents for cancer research and diagnostics. BD (Becton, Dickinson and Company) and Abbott Laboratories round out the list, each providing unique contributions to technological advancements and products Show Less Read more